Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

165
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
165

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Cenobamate: A Review in Focal-Onset Seizures.

CNS drugs·2025
Same author

Ozanimod: A Review in Relapsing Forms of Multiple Sclerosis.

CNS drugs·2024
Same author

Talicabtagene Autoleucel: First Approval.

Molecular diagnosis & therapy·2024
Same author

Bimekizumab: A Review in Psoriatic Arthritis.

Drugs·2024
Same author

Correction: Eplontersen: First Approval.

Drugs·2024
Same author

Vutrisiran: A Review in Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis.

Drugs·2023

相关实验视频

Updated: Jul 2, 2025

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

18.2K

埃普隆特森:第一次获得批准

Tina Nie1

  • 1Springer Nature, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand. dru@adis.com.

Drugs
|February 27, 2024
PubMed
概括

埃普隆特森显著降低了TTR蛋白水平,并减缓了继承性跨甲基素中介性粉症 (hATTR-PN) 中的神经病变的进展. 这导致其最近获得美国批准用于治疗这种罕见疾病.

科学领域:

  • 药理学 药理学是指药理学的学科.
  • 遗传学 是一个遗传学.
  • 神经学 神经学

背景情况:

  • 晶氨酸中介性粉症 (ATTR) 是一种由错误折叠的晶氨酸 (TTR) 蛋白引起的渐进性疾病.
  • ATTR导致神经和器官中的粉样蛋白沉积,导致显著的发病率和死亡率.
  • 目前的治疗方法有限,这凸显了对新型治疗方法的需求.

研究的目的:

  • 总结一下eplontersen的开发,这是一种用于治疗ATTR的新型反感性寡核酸.
  • 要突出关键的里程碑,导致监管部门批准eplontersen的ATTRv-PN.

主要方法:

  • 埃普隆特森是一种合联体的反感性寡核酸,向肝脏中的TTR mRNA.
  • 它利用N-乙银胺残留物进行有针对性的输送.
  • 第三期临床试验评估了ATTRv-PN.患者的疗效和安全性.

主要成果:

  • 皮下eplontersen证明了血清TTR水平的降低.
  • 治疗抑制了ATTRv-PN.患者的神经病变的进展.
  • 与健康相关的生活质量在接受治疗的患者中呈现改善.

更多相关视频

Platelet-Rich Plasma Lysate for Treatment of Eye Surface Diseases
05:57

Platelet-Rich Plasma Lysate for Treatment of Eye Surface Diseases

Published on: August 2, 2022

4.1K
Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay
07:52

Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay

Published on: September 10, 2018

8.8K

相关实验视频

Last Updated: Jul 2, 2025

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

18.2K
Platelet-Rich Plasma Lysate for Treatment of Eye Surface Diseases
05:57

Platelet-Rich Plasma Lysate for Treatment of Eye Surface Diseases

Published on: August 2, 2022

4.1K
Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay
07:52

Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay

Published on: September 10, 2018

8.8K

结论:

  • 埃普隆特森代表了ATTRv-PN.治疗的重大进展.
  • 药物的向机制有效地降低了TTR蛋白和粉样蛋白负担.
  • 美国的监管批准和其他地区正在进行的审查表明其治疗潜力.